BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 11221094)

  • 21. [Histoid leprosy with erythema nodosum leprosum].
    Alioua Z; Sbai M; Elhaouri M; Bouzidi A; Boudi O; Ghfir M; Benomar S; Sedrati OL
    Acta Leprol; 2003; 12(3):107-11. PubMed ID: 15040700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hansen's disease mimicking palmoplantar keratoderma.
    Agrawal US; Saxena A; Meena RS; Saini M; Saxena V
    Int J Lepr Other Mycobact Dis; 2002 Sep; 70(3):210-2. PubMed ID: 12483971
    [No Abstract]   [Full Text] [Related]  

  • 23. Leprosy: not always an easy diagnosis and often a management challenge.
    Manifold R; Marshman G
    Australas J Dermatol; 2009 Feb; 50(1):36-40. PubMed ID: 19178490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leprosy.
    Walker SL; Lockwood DN
    Clin Dermatol; 2007; 25(2):165-72. PubMed ID: 17350495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A case of leprosy mistaken for cutaneous sarcoidosis.
    Aftab H; Nielsen SD; Nielsen SL; Due E; Bygbjerg IC; Thybo S
    Acta Derm Venereol; 2012 Mar; 92(2):189-90. PubMed ID: 22101923
    [No Abstract]   [Full Text] [Related]  

  • 26. [Patient with Hansen disease and lepromatous reaction with predominant neural involvement].
    Gálvez J; López-Domínguez JM; Navarro A; Creagh R; Casado JL; Chinchón Lara I
    Neurologia; 1998 Jan; 13(1):41-4. PubMed ID: 9522583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hansen's disease (Leprosy): current and future pharmacotherapy and treatment of disease-related immunologic reactions.
    Legendre DP; Muzny CA; Swiatlo E
    Pharmacotherapy; 2012 Jan; 32(1):27-37. PubMed ID: 22392826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dapsone-induced motor polyneuropathy in a patient with leprosy.
    Pavithran K; Satish TC
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):262-3. PubMed ID: 9251603
    [No Abstract]   [Full Text] [Related]  

  • 29. Half a Century in Hiding: A Unique Case of Tuberculoid Leprosy with an Unprecedented Incubation Period.
    Rajani AJ; Raval DM; Chitale RA; Kempaiah P; Elwasila SM; Durvasula R; Oring J
    Am J Case Rep; 2024 Feb; 25():e942048. PubMed ID: 38351602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Type I reaction in a borderline leprosy case successfully treated with multidrug therapy and ofloxacin.
    Asz-Sigall D; López-García L; Neme-Yunes Y; Yuen-Palos R; Vega-Memije ME; Arenas R
    Int J Dermatol; 2008 Oct; 47(10):1084-6. PubMed ID: 18986365
    [No Abstract]   [Full Text] [Related]  

  • 31. A overview of ocular leprosy after 2 decades of multidrug therapy.
    Lewallen S; Courtright P
    Int Ophthalmol Clin; 2007; 47(3):87-101. PubMed ID: 17667278
    [No Abstract]   [Full Text] [Related]  

  • 32. Paucibacillary treatment for large tuberculoid lesions of leprosy?
    Santos MN; de Ferreira LC; Talhari S
    Int J Lepr Other Mycobact Dis; 2005 Sep; 73(3):225-7; author reply 227-8. PubMed ID: 16830649
    [No Abstract]   [Full Text] [Related]  

  • 33. A case of leprosy in central Florida.
    Anderson KL; Minni JP; Nowak MA; Karai LJ; Sanik E
    Cutis; 2017 Nov; 100(5):327-329. PubMed ID: 29232423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dapsone drug resistance in the MDT era.
    Roche PW; Neupane KD; Failbus SS; Butlin CR
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097
    [No Abstract]   [Full Text] [Related]  

  • 35. A high incidence of viable Mycobacterium leprae in post-MDT recurrent lesions in tuberculoid leprosy patients.
    Shetty VP; Wakade A; Antia NH
    Lepr Rev; 2001 Sep; 72(3):337-44. PubMed ID: 11715280
    [No Abstract]   [Full Text] [Related]  

  • 36. Primary hyperpigmented palmar lesion: a rare presentation of borderline tuberculoid leprosy.
    Grover S; Singh G; Dash K
    Indian J Lepr; 1997; 69(2):191-3. PubMed ID: 9290973
    [No Abstract]   [Full Text] [Related]  

  • 37. [Immuno-allergic accidents with rifamipcin].
    Flageul B; Wagner L; Cottenot F
    Acta Leprol; 2001-2002; 12(2):71-8. PubMed ID: 12136739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Borderline tuberculoid leprosy in childhood onset systemic lupus erythematosus patient.
    Lopes VA; Lourenço DM; Guariento A; Trindade MA; Avancini J; Silva CA
    Lupus; 2015 Nov; 24(13):1448-51. PubMed ID: 26113359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reactional tattoo inoculation borderline tuberculoid leprosy with oedematous tattoos.
    Ghorpade A
    Lepr Rev; 2004 Mar; 75(1):91-4. PubMed ID: 15072131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prevalence of folP1 mutations associated with clinical resistance to dapsone, in Mycobacterium leprae isolates from South Korea.
    Lee SB; Kim SK; Kang TJ; Chae GT; Chun JH; Shin HK; Kim JP; Ko YH; Kim NH
    Ann Trop Med Parasitol; 2001 Jun; 95(4):429-32. PubMed ID: 11454253
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.